United States-based Innova Medical Group Inc announced on Monday that it has named Sean Rogers as the chairman of Innova Medical Group and Todd Malan, MD as its new chief medical officer.
Prior to joining Innova Medical Group, Rogers was the global head of Technology Strategy and Solutions. He was also chief executive officer of Pasaca Capital.
Dr Malan was the senior vice president of clinical research at Quantum Material Corporation. He was previously the chief medical officer for iQuantum Labs, founded the investigational research for adipose derived cell therapies at the Center for Regenerative Cell Medicine, and served as medical director for adipose tissues services at Celebration Stem Cell Labs in Arizona.
Dexcom highlights new diabetes outcomes and product roadmap at ATTD 2026
Curatis and Neupharma partner to develop corticorelin for peritumoral brain edema in Japan
Samsung Biologics collaborates with Lilly for new Gateway Labs site in Korea
Citius Oncology reports positive topline results from Phase 1 clinical trial of LYMPHIR combination
GenomOncology partners with WeTrials to support CNS cancer clinical trials
Target ALS awards two-year research grant to AcuraStem for advancing therapeutics targeting SYF2
Ascletis reports Phase II weight‑loss results for ASC30 depot formulation
NS Pharma and NCNP report 4.5-year brogidirsen data for DMD treatment
Biofrontera reports Phase 2b data for Ameluz photodynamic therapy in acne vulgaris treatment
Koselugo approved in Canada for adults with NF1 and inoperable plexiform neurofibromas
Bristol Myers Squibb reports positive Phase 3 results for oral mezigdomide in multiple myeloma
Pfizer reports positive Phase 2 results for trispecific antibody in atopic dermatitis
Agilent to acquire Biocare Medical for USD950m to expand pathology portfolio